Healthcare -
Biotechnology - NASDAQ - US
$ 3.7
-3.27 %
$ 36.2 M
Market Cap
-0.15
P/E
BLUE - REVENUE
Revenue BLUE - bluebird bio, Inc.
83.8 M
LAST VALUE
382.69%
2 YEAR CAGR
13.41%
5 YEAR CAGR
12.67%
10 YEAR CAGR